These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 29424318)

  • 1. The Significance of Pain in Chronic Venous Disease and its Medical Treatment.
    Radak D; Atanasijević I; Nešković M; Isenovic E
    Curr Vasc Pharmacol; 2019; 17(3):291-297. PubMed ID: 29424318
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of micronized purified flavonoid fraction (Daflon®) on improving individual symptoms, signs and quality of life in patients with chronic venous disease: a systematic review and meta-analysis of randomized double-blind placebo-controlled trials.
    Kakkos SK; Nicolaides AN
    Int Angiol; 2018 Apr; 37(2):143-154. PubMed ID: 29385792
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Micronized Purified Flavonoid Fraction (MPFF) for Patients Suffering from Chronic Venous Disease: A Review of New Evidence.
    Ulloa JH
    Adv Ther; 2019 Mar; 36(Suppl 1):20-25. PubMed ID: 30758743
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum.
    Gloviczki P; Comerota AJ; Dalsing MC; Eklof BG; Gillespie DL; Gloviczki ML; Lohr JM; McLafferty RB; Meissner MH; Murad MH; Padberg FT; Pappas PJ; Passman MA; Raffetto JD; Vasquez MA; Wakefield TW; ;
    J Vasc Surg; 2011 May; 53(5 Suppl):2S-48S. PubMed ID: 21536172
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CVD: a condition of underestimated severity.
    Lattimer CR
    Int Angiol; 2014 Jun; 33(3):222-8. PubMed ID: 24732585
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The prevalence, disease characteristics and treatment of chronic venous disease: an international web-based survey.
    Rabe E; Régnier C; Goron F; Salmat G; Pannier F
    J Comp Eff Res; 2020 Dec; 9(17):1205-1218. PubMed ID: 33079592
    [No Abstract]   [Full Text] [Related]  

  • 7. The Center for Vein Restoration Study on presenting symptoms, treatment modalities, and outcomes in Medicare-eligible patients with chronic venous disorders.
    Pappas PJ; Lakhanpal S; Nguyen KQ; Vanjara R
    J Vasc Surg Venous Lymphat Disord; 2018 Jan; 6(1):13-24. PubMed ID: 29248102
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of chronic venous disorders of the lower limbs: guidelines according to scientific evidence.
    Nicolaides AN; Allegra C; Bergan J; Bradbury A; Cairols M; Carpentier P; Comerota A; Delis C; Eklof B; Fassiadis N; Georgiou N; Geroulakos G; Hoffmann U; Jantet G; Jawien A; Kakkos S; Kalodiki E; Labropoulos N; Neglen P; Pappas P; Partsch H; Perrin M; Rabe E; Ramelet AA; Vayssaira M; Ioannidou E; Taft A
    Int Angiol; 2008 Feb; 27(1):1-59. PubMed ID: 18277340
    [No Abstract]   [Full Text] [Related]  

  • 9. Advantages and disadvantages of graduated and inverse graduated compression hosiery in patients with chronic venous insufficiency and healthy volunteers: A prospective, mono-centric, blinded, open randomised, controlled and cross-over trial.
    Riebe H; Konschake W; Haase H; Jünger M
    Phlebology; 2018 Feb; 33(1):14-26. PubMed ID: 27932625
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Varicose veins.
    Piazza G
    Circulation; 2014 Aug; 130(7):582-7. PubMed ID: 25114187
    [No Abstract]   [Full Text] [Related]  

  • 11. Association of Venous Disorders with Leg Symptoms: Results from the Bonn Vein Study 1.
    Wrona M; Jöckel KH; Pannier F; Bock E; Hoffmann B; Rabe E
    Eur J Vasc Endovasc Surg; 2015 Sep; 50(3):360-7. PubMed ID: 26141786
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Management of varicose veins and venous insufficiency.
    Hamdan A
    JAMA; 2012 Dec; 308(24):2612-21. PubMed ID: 23268520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Varicose veins and chronic venous insufficiency.
    Partsch H
    Vasa; 2009 Nov; 38(4):293-301. PubMed ID: 19998250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Sulodexide: it is time for a program against chronic venous disease.
    Roztocil K; Antignani PL
    Int Angiol; 2014 Jun; 33(3):209-11. PubMed ID: 24936530
    [No Abstract]   [Full Text] [Related]  

  • 15. Recommendations for the medical management of chronic venous disease: The role of Micronized Purified Flavanoid Fraction (MPFF).
    Bush R; Comerota A; Meissner M; Raffetto JD; Hahn SR; Freeman K
    Phlebology; 2017 Apr; 32(1_suppl):3-19. PubMed ID: 28211296
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Efficacy of micronized purified flavonoid fraction in treatment of chronic venous oedema].
    Bogachev VI; Boldin BV; Turkin PI; Samenkov AI
    Angiol Sosud Khir; 2020; 26(2):86-94. PubMed ID: 32597888
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevalence of venous insufficiency in French adults of the SUVIMAX cohort. SUpplémentation en VItamines et Minéraux AntioXydants.
    Preziosi P; Galan P; Aissa M; Hercberg S; Boccalon H
    Int Angiol; 1999 Jun; 18(2):171-5. PubMed ID: 10424376
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Compliance in pharmacotherapy in patients with chronic venous disorders.
    Chudek J; Kocełak P; Ziaja D; Owczarek A; Ziaja K
    Int Angiol; 2012 Aug; 31(4):393-401. PubMed ID: 22801406
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of chronic venous insufficiency in Latin America.
    Javier JJ; Ortiz P
    J Vasc Surg Venous Lymphat Disord; 2020 Jul; 8(4):667-675. PubMed ID: 32234293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of varicose veins: what do the clinical signs and symptoms reveal about the underlying disease and need for intervention?
    Marston WA
    Semin Vasc Surg; 2010 Jun; 23(2):78-84. PubMed ID: 20685561
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.